Gland Pharma has named Ajay Sahni as the new CEO of its Singapore subsidiary, Gland Singapore, effective November 2, 2026.
Sanofi is set to pursue larger acquisitions and enhance its growth strategy under the leadership of CEO Belen Garijo, aiming ...
Senores Pharmaceuticals has announced its Q2 FY27 financial results, showcasing a 25% increase in revenue to ₹192 crore, ...
India’s medicine sales grow in double digits for four straight quarters, led by chronic care drugs
India's pharmaceutical industry has experienced unprecedented double-digit growth over the past four quarters, driven mainly by chronic care drug sales. Expectations of sustainable growth continue as ...
Laurus Labs expands its capabilities in the oligonucleotide and peptide sectors with strategic acquisitions, enhancing R&D, ...
Granules India receives a form 483 from the FDA with 11 observations during inspection, highlighting process and documentation improvements needed at their Gagillapur facility. No data integrity or ...
Wockhardt reports a 24% increase in Q2 revenue, reaching ₹939 crore, but net profit drops as the company invests heavily in ...
Fresenius has entered a major development agreement with WuXi Biologics to enhance its biosimilars pipeline, targeting a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results